The covariates were adjusted in the PSM model for a priori-identified potential confounders, such as age, sex, race/ethnicity, nicotine dependence, BMI, type 2 diabetes, hypertension, hyperlipidaemia, hypercholesterolaemia, chronic respiratory disease, chronic renal diseases, BP, chronic kidney disease, peripheral vascular diseases, diabetes-related microvascular complications, glomerular diseases, cirrhosis of the liver, osteoporosis, sleep apnoea, abnormal laboratory findings (HbA 1c , serum cholesterol, LDL-cholesterol, HDL-cholesterol and triacylglycerol [TG]) and intake of cardiovascular medications (Table 1)
Maroon obtained his medical and neurosurgical training at Indiana University, Georgetown University, Oxford University in England and the University of Vermont
The review, published on August 14 in Its important to note that all three studies can only identify correlations and cannot establish that taking a GLP-1 causes these eye disorders
Nutr Rev 76(8):603617
For each of these diseases, we performed a new search on Pubmed using CoQ 10 /coenzyme Q 10 /ubiquinone supplementation cardiovascular disease/heart failure/coronary artery disease/kidney disease/kidney failure/end-stage renal disease/nephrotic syndrome/chronic obstructive pulmonary disease/NAFLD/neurodegenerative disease/Alzheimers disease/Parkinsons disease/multiple system atrophy oxidative stress
Contact your healthcare provider if you experience severe abdominal pain, repeated vomiting, or frequent dosing difficulties
